Arcturus therapeutics announces initiation of dosing arct-810 in patients with ornithine transcarbamylase (otc) deficiency

San diego--(business wire)---- $arct #clinicaltrial--arcturus therapeutics announces initiation of dosing arct-810 in patients with ornithine transcarbamylase (otc) deficiency

ARCT Ratings Summary

ARCT Quant Ranking